Clinical Trials Browser

Phase 1 × INDUSTRY × filanesib × Clear all

NCT01248923 2020-09-30

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Paraproteinemias, Plasmacytoma

NCT00462358 2020-09-28

A Study of ARRY-520 in Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors